MIST Stock Price
Milestone Pharmaceuticals Inc.
MIST stock price is $0.79 (+2.89% on the day), giving Milestone Pharmaceuticals Inc. a market cap of $98.09M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MIST Stock Overview
- Price
- $0.79
- Previous close
- $0.77
- Open
- $0.76
- Market cap
- $98.09M
- P/E ratio
- -1.6
- 52-week range
- $0.71 - $3.06
- 1-year price target
- $5.86
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 27
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which completed Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montréal, Canada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIST | $0.79 | +2.9% | 807.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Milestone Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW